Evidence map›Paper›PMID 31659105›Full record

ArticleCancer genomics & proteomics

Synergism of Adipocytokine Profile and

Rosa Divella, Antonella Daniele, Raffaele DE Luca, Antonio Mazzocca, Eustachio Ruggieri, Eufemia Savino, Porzia Casamassima, Michele Simone, Carlo Sabba, Angelo Paradiso

Open access · diamondAbstract read
In one paragraph

Article in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Rosa DivellaInstitutional BioBank, Experimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy rosadive@inwind.it.
Antonella DanieleInstitutional BioBank, Experimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Raffaele DE LucaDepartment of Surgery Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Antonio MazzoccaInterdisciplinary Department of Medicine, University of Bari School of Medicine, Bari, Italy.
Eustachio RuggieriDepartment of Surgery Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Eufemia SavinoClinical Pathology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Porzia CasamassimaClinical Pathology Laboratory, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Michele SimoneDepartment of Surgery Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Carlo SabbaInterdisciplinary Department of Medicine, University of Bari School of Medicine, Bari, Italy.
Angelo ParadisoInstitutional BioBank, Experimental Oncology and Biobank Management Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Tumori Bari · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimThe aim of this study was to evaluate whether the altered profile of adipocytokine and genetic fingerprint in NAFLD-associated metabolic syndrome "cluster" represents synergistic risk factors predicting onset of liver colorectal cancer metastases. MATERIALS AND

methodsA total of 165 colorectal cancer patients were enrolled, 56,3% were with metabolic syndrome/NAFLD. Serum samples were assayed for ADIPOQ, leptin and TNF-a levels by ELISA. ADIPOQ rs266729 C/G and TNF-308 A/G genotypes were analyzed in DNA isolated from whole blood.

resultsReduction in adiponectin levels and increase in leptin and TNF-α was shown in patients with liver metastases. This trend was influenced by BMI, MetS/NAFLD, and insulin resistance. ADIPOQ G rs266729 and TNF- 308 A allele are associated with obesity, MetS/NAFLD and insulin resistance. ADIPOQ CG/GG and GA/AA TNF-alpha genotypes confer susceptibility to liver metastases.

conclusionObesity and hepatic steatosis significantly favor the development of colorectal cancer liver metastases and the individual adipocytokines genetic profile may play an important predictive role.

Indexed as

AdiponectinColorectal NeoplasmsLiver NeoplasmsNeoplasm ProteinsNon-alcoholic Fatty Liver DiseasePolymorphism, GeneticTumor Necrosis Factor-alphaAdultAllelesFemaleHumansMaleMiddle AgedNeoplasm MetastasisObesityAdiponectinADIPOQ protein, humanNeoplasm ProteinsTumor Necrosis Factor-alphaAdiponectincolorectal cancerleptinmetabolic syndromeNAFLDobesityTNF-α

Identifiers

PMID31659105
PMCPMC6885361
OpenAlexW2982416924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.